Europe · Business news
85 stories · latest 07 Oct 2026 · clear filter
Fresenius Medical Care runs 3,513 dialysis clinics treating about 290,000 patients, and under Giza it finished a programme that took about €1.2 billion out of its cost base. The change comes with five days' notice…
The move in French debt matters most to banks and insurers that hold it and to French companies whose borrowing costs follow the sovereign; it reverses part of the sell-off that took the CAC 40 to a six-month low on…
The increase answers activist investor Palliser Capital, which argued the first price undervalued the company and asked for at least €60 a share; the new terms are still well below that, so minority holders now choose…
Epcoritamab, sold as EPKINLY in the US and Japan and TEPKINLY in the EU, is approved so far for lymphoma that has returned after earlier treatment. A first-line label would open a much larger group of patients, and…
The split shows the bond selloff is now a country story inside Europe. Higher French government yields raise funding costs for French banks, insurers and heavily indebted companies and lower the value of the sovereign…
Full ownership means Fresenius keeps all of mAbxience's profit instead of sharing 45% with minority holders, and controls its biosimilar pipeline and manufacturing capacity outright within its Kabi division. The price…
With the ECB raising rates and the SNB at zero, the rate gap favours the euro over the franc, easing currency headwinds for Swiss exporters that book costs in francs and sell abroad, such as Novartis, Roche, Nestlé…
Novo Nordisk is among the largest companies listed in the Nordic region, so its guidance carries weight in European health-care indices on its own. The exposure is US obesity-drug volumes and net prices after rebates…
By delivering the EU's side of the deal, the agreement supports the 15% US tariff ceiling that matters most for European carmakers such as Volkswagen, BMW, Mercedes-Benz and Stellantis, and the exclusions that keep…
The delay gives European software and industrial groups that build AI into their products, such as SAP, Siemens and Dassault Systèmes, as well as medical-device makers, more time and lower near-term compliance…